15 results
6-K
EX-10.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Current report (foreign)
5:28pm
the indemnified party would present such counsel with a conflict of interest, (ii) the actual or potential defendants in, or targets of, any such action include
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Sep 23
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar
7:49am
targets specifically Sars-Cov-2, we believe that our tests are adaptable to a broad range of immunological threats in different settings, from personal
20-F
2022 FY
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Aug 22
Annual report (foreign)
4:20pm
existing businesses and products and services. Our ideal targets include companies with strong capabilities in developing diagnostic kits for viral
424B4
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
21 Jul 22
Prospectus supplement with pricing info
10:01am
and products and services. Our ideal targets include companies with strong capabilities in developing diagnostic kits for viral diseases, in particular … acquisition targets to bring under our umbrella, and we entered into a non-binding letter of intent with a European Union based materials technology
F-1/A
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
selective investments and acquisitions that complement and create synergies with our existing businesses and products and services. Our ideal targets include … . As of the date of this prospectus, we have identified two strategic assets acquisition as potential acquisition targets to bring under our umbrella
F-1/A
mvtcf dnos2
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
ccf4 zc4wfhds653hle
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
jomq iaxx
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
w10o6gq 3d
11 May 22
Registration statement (foreign) (amended)
3:11pm
F-1/A
o4xnr813vn5twte
22 Apr 22
Registration statement (foreign) (amended)
6:09pm
CORRESP
9m0que
22 Apr 22
Correspondence with SEC
12:00am
UPLOAD
m8ft8b24
7 Apr 22
Letter from SEC
12:00am
F-1
8z4496ifg8wljgm327o3
18 Mar 22
Registration statement (foreign)
3:50pm
DRS/A
sdl64ss1wad43cuis
17 Feb 22
Draft registration statement (amended)
12:00am
DRS
6r1uw udk5l
27 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next